The Boston Celtics are cautiously optimistic about Jayson Tatum’s potential return this season following his Achilles tendon rupture in the 2025 playoffs.
Shams Charania told Pat McAfee on October 9 that while other superstars like Damian Lillard and Tyrese Haliburton have been ruled out for the season, Tatum remains on track to possibly play.
Tatum, who signed a five-year, $314 million contract in July 2024, suffered the non-contact Achilles injury on May 12 during Game 4 of the second-round playoffs against the New York Knicks. The injury occurred as he dove for a loose ball, ending his 2024–25 campaign prematurely.
Despite the setback, Celtics officials see potential for a return, though much depends on medical clearances and team context later in the season. Charania noted that even if Tatum reaches full health by March, team performance and strategic considerations could influence the decision to play him.
Tatum had an exceptional 2024–25 season before the injury, averaging 28.1 points, 11.5 rebounds, and 5.4 assists over eight playoff games. He also recorded historic free-throw efficiency, going 37-for-37 over a three-game span in the first playoff round and achieving three consecutive 35-point games, joining Larry Bird as the only Celtics to do so.
Boston’s star forward had also reached career milestones during the regular season, including multiple 40-point games and recording a season-high 46 points with 16 rebounds and nine assists against the Cavaliers. His all-around performance solidified his status as one of the league’s top talents.
While the Celtics are hopeful, returning from an Achilles tear is a significant challenge. Players like Lillard and Haliburton, who suffered similar injuries, are sidelined for the entire season, underscoring the difficulty and uncertainty of Tatum’s recovery timeline.
Medical evaluations and incremental progress over the next several months will determine whether Tatum can contribute this season.
